Since a mutation of p53 is critical to colon cancer development [30-33], the anti-proliferative properties of genistein may relate to targeting mutated p53 and thus promoting FOXO3 activity and cell cycle arrest. The gene discussed is FOXO3; the disease is malignant colon neoplasm.